Breast cancer among hispanic and non-hispanic white women in Arizona

Journal of Health Care for the Poor and Underserved

Volumn 18, Issue 4 SUPPL., 2007, Pages 130-145

  Martínez, María Elena ^a,b   Nielson, Carrie M ^a   Nagle, Ray ^a   Lopez, Ana Maria ^a,c   Kim, Christina ^a,d   Thompson, Patricia ^a  

^a UNIVERSITY OF ARIZONA   (United States)

^b UNIVERSITY OF ARIZONA   (United States)

^c Department of Pathology ^*

^d UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

Author keywords

Arizona; Breast neoplasms; Carcinoma, ductal, breast; Hispanics; Mexican Americans; Southwestern United States

Indexed keywords

ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR;

ADOLESCENT; ADULT; AGED; ARTICLE; BREAST TUMOR; CANCER REGISTRY; CANCER STAGING; CAUCASIAN; DISEASE COURSE; ETHNOLOGY; FEMALE; HISPANIC; HUMAN; MIDDLE AGED; PATHOLOGY; RISK; STATISTICAL MODEL; STATISTICS; UNITED STATES;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ARIZONA; BREAST NEOPLASMS; DISEASE PROGRESSION; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HISPANIC AMERICANS; HUMANS; LOGISTIC MODELS; MIDDLE AGED; NEOPLASM STAGING; ODDS RATIO; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; SEER PROGRAM;

EID: 38049169143     PISSN: 10492089     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (65)

1. Parkin DM, Whelan SL, Ferlay J, et al., eds. Cancer incidence in five continents. Vol. VIII. France: International Agency for Research on Cancer, 2002.
2. Howe HL, Wu X, Ries LA, et al. Annual report to the nation on the status of cancer, 1975-2003, featuring cancer among U.S. Hispanic/Latino populations. Cancer. 2006 Oct 15;107(8):1711-42.
3. American Cancer Society (ACS). Cancer facts & figures for Hispanics/Latinos 2006-2008. Atlanta: ACS, 2006.
4. American Cancer Society. Cancer facts & figures 2006. Atlanta: ACS, 2006.
5. Elledge RM, Clark GM, Chamness GC, et al. Tumor biologic factors and breast cancer prognosis among white, Hispanic, and black women in the United States. J Natl Cancer Inst. 1994 May 4;86(9):705-12.
6. Hedeen AN, White E. Breast cancer size and stage in Hispanic American women, by birthplace: 1992-1995. Am J Public Health. 2001 Jan;91(1):122-5.
7. Bayer-Chammard A, Taylor TH, Anton-Culver H. Survival differences in breast cancer among racial/ethnic groups: a population-based study. Cancer Detect Prev. 1999;23(6):463-73.
8. Clegg LX, Li FP, Hankey BF, et al. Cancer survival among US Whites and minorities: a SEER (Surveillance, Epidemiology, and End Results) Program. Arch Intern Med. 2002 Sep;162(17):1985-93.
9. Shavers VL, Harlan LC, Stevens JL. Racial/ethnic variation in clinical presentation, treatment, and survival among breast cancer patients under 35. Cancer. 2003 Jan 1; 97(1):134-47.
10. Miller BA, Hankey BF, Thomas TL. Impact of sociodemographic factors, hormone receptor status, and tumor grade on ethnic differences in tumor stage and size for breast cancer in US women. Am J Epidemiol. 2002 Mar 15;155(6):534-45.
11. Lantz PM, Mujahid M, Schwartz K, et al. The influence of race, ethnicity, and individual socioeconomic factors on breast cancer stage and diagnosis. Am J Public Health. 2006 Dec;96(12):2173-8.
12. Boyle T, McPadden E. Breast cancer presents at earlier age in Mexican American women. Breast J. 2004 Sep-Oct;10(5):462-4.
13. Watlington AT, Byers T, Mouchawar J, et al. Does having insurance affect differences in clinical presentation between Hispanic and non-Hispanic white women with breast cancer? Cancer. 2007 May;109(10):2093-9.
14. Sorlie T, Tibshirani R, Parker J, et al. Repeated observation of breast tumor subtypes in independent gene expression data sets. Proc Natl Acad Sci USA. 2003 Jul 8; 100(14):8418-23.
15. Colditz GA, Rosner BA, Chen WY, et al. Risk factors for breast cancer according to estrogen and progesterone receptor status. J Natl Cancer Inst. 2004 Feb 4;96(3): 218-28.
16. Sorlie T, Wang Y, Xiao C, et al. Distinct molecular mechanisms underlying clinically relevant subtypes of breast cancer: gene expression analyses across three different platforms. BMC Genomics. 2006 May 26;7:127.
17. Tamoxifen for early breast cancer: an overview of the randomized trials. Early Breast Cancer Triaists' Collaborative Group. Lancet. 1998 May 16;351(9114):1451-67.
18. Cui X, Schiff R, Arpino G, et al. Biology of progesterone receptor loss in breast cancer and its implications for endocrine therapy. J Clin Oncol. 2005 Oct 20;23(30):7721-35.
19. Ma H, Bernstein L, Pike MC, et al. Reproductive factors and breast cancer risk according to joint estrogen and progesterone receptor status: a meta-analysis of epidemiological studies. Breast Cancer Res. 2006;8(4):R43.
20. Ursin G, Bernstein L, Lord SJ, et al. Reproductive factors and subtypes of breast cancer defined by hormone receptor and histology. Br J Cancer. 2005 Aug 8;93(3):364-71.
21. Chu KC, Anderson WF. Rates for breast cancer characteristics by estrogen and progesterone receptor status in the major racial/ethnic groups. Breast Cancer Res Treat. 2002 Jun;74(3):199-211.
22. Li CI, Malone KE, Daling JR. Differences in breast cancer hormone receptor status and histology by race and ethnicity among women 50 years of age and older. Cancer Epidemiol Biomarkers Prev. 2002 Jul;11(7):601-7.
23. Joslyn SA. Hormone receptors in breast cancer: racial differences in distribution and survival. Breast Cancer Res Treat. 2002 May;73(1):45-59.
24. Howe HL, Chen VW, Hotes JL, et al., eds. Cancer in North America, 1994-1998. Volume One: Incidence. Springfield, IL: North American Association of Central Cancer Registries, Inc., 2001.
25. Howard CA, Samet JM, Buechley RW, et al. Survey research in New Mexico Hispanics: some methodological issues. Am J Epidemiol. 1983 Jan;117(1):27-34.
26. Woodward WA, Vinh-Hung V, Ueno NT, et al. Prognostic value of nodal ratios in node-positive breast cancer. J Clin Oncol. 2006 Jun 20;24(18):2910-6.
27. Young JL Jr, Roffers SD, Ries LAG, et al., eds. SEER summary staging manual - 2000: codes and coding instructions. (NIH Pub. No. 01-4969.) Bethesda, MD: National Cancer Institute, 2001.
28. Fritz AG, Percy C, Jack A, et al., eds. International classification of diseases for oncology (ICD-O), 3rd Ed. Geneva, Switzerland: WHO Press, 2000.
29. Percy C, Van Holten V, Muir C. International Classification of Diseases for Oncology (ICD-O), 2nd Ed. Geneva, Switzerland: WHO Press, 1995.
30. Yancik R, Ries LG, Yates JW. Breast cancer in aging women. A population-based study of contrasts in stage, surgery, and survival. Cancer. 1989 Mar 1;63(5):976-81.
31. von Rosen A, Gardelin A, Auer G. Assessment of malignancy potential in mammary carcinoma in elderly patients. Am J Clin Oncol. 1987 Feb;10(1):61-4.
32. Diab SG, Elledge RM, Clark GM. Tumor characteristics and clinical outcome of elderly women with breast cancer. J Natl Cancer Inst. 2000 Apr 5;92(7):550-6.
33. Joslyn SA, West MM. Racial differences in breast carcinoma survival. Cancer. 2000 Jan 1;88(1):114-23.
34. Eley JW, Hill HA, Chen VW, et al. Racial differences in survival from breast cancer. Results of the National Cancer Institute Black/White Cancer Survival Study. JAMA. 1994 Sep 28;272(12):947-54.
35. Ragland KE, Selvin S, Merrill DW. Black-white differences in stage-specific cancer survival: analysis of seven selected sites. Am J Epidemiol. 1991 Apr 1;133(7):672-82.
36. U.S. Census Bureau. Population by race and Hispanic or Latino origin, for the United States: 2000 (PHC-T-9). Washington, DC: U.S. Census Bureau, 2001. Available at http://www.census.gov/population/www/cen2000/phc-t9.html.
37. Olsson H. Tumour biology of a breast cancer at least partly reflects the biology of the tissue/epithelial cell of origin at the time of initiation - a hypothesis. J Steroid Biochem Mol Biol. 2000 Nov 30;74(5):345-50.
38. Rosen PP, Oberman HA. Tumors of the mammary gland. Washington, DC: Armed Forces Institute of Pathology, 1993.
39. Styblo TM, Wood WC. Traditional prognostic factors for breast cancer. In: Bland KI, Copeland EM 3rd, eds. The breast: comprehensive management of benign and malignant diseases, 2nd Ed. Philadelphia: WB. Saunders Company, 1998; 419-27.
40. Cianfrocca M, Goldstein LJ. Prognostic and predictive factors in early-stage breast cancer. Oncologist. 2004;9(6):606-16.
41. Singletary SE, Allred C, Ashley P, et al. Revision of the American Joint Committee on Cancer staging system for breast cancer. J Clin Oncol. 2002 Sep 1;20(17):3628-36.
42. American Cancer Society (ACS). Breast cancer facts & figures, 2005-2006. Atlanta: ACS, 2005.
43. Bast RC Jr, Ravdin P, Hayes DF, et al. 2000 update of recommendations for the use of tumor markers in breast and colorectal cancer: clinical practice guidelines of the American Society of Clinical Oncology. J Clin Oncol. 2001 Mar 15;19(6):1865-78.
44. Esteva FJ, Hortobagyi G. Prognostic molecular markers in early breast cancer. Breast Cancer Res. 2004 6(3):109-18.
45. Simpson JF, Wilkinson EJ. Malignant neoplasia of the breast: infiltrating carcinomas. In: Bland KI, Copeland EM 3rd, eds. The breast: comprhensive management of benign and malignant diseases, 2nd Ed. Philadelphia: W.B. Saunders Company, 1998; 289.
46. Li R, Gilliland FD, Baumgartner K, et al. Hormone replacement therapy and breast carcinoma risk in Hispanic and non-Hispanic women. Cancer. 2002 Sep 1;95(5): 960-8.
47. Newell DA, Markides KS, Ray LA, et al. Postmenopausal hormone replacement therapy use by older Mexican-American women. J Am Geriatr Soc. 2001 Aug;49(8): 1046-51.
48. Borgquist S, Anagnostaki L, Jirström K, et al. Breast tumors following combined hormone replacement therapy express favourable prognostic factors. Int J Cancer. 2007 May 15;120(10):2202-7.
49. Li CI, Uribe DJ, Daling JR. Clinical characteristics of different histologic types of breast cancer. Br J Cancer. 2005 Oct 31;93(9):1046-52.
50. Anderson WF, Chu KC, Chang S, et al. Comparison of age-specific incidence rate patterns for different histopathologic types of breast carcinoma. Cancer Epidemiol Biomarkers Prev. 2004 Jul;13(7):1128-35.
51. Ridolfi RL, Rosen PP, Port A, et al. Medullary carcinoma of the beast: a clinicopathologic study with a ten-year follow-up. Cancer. 1977 Oct;40(4):1365-85.
52. Eichhorn JH. Medullary carcinoma, provocative now as then. Semin Diagn Pathol. 2004 Feb;21(1):65-73.
53. Bertucci F, Finetti P, Cervera N, et al. Gene expression profiling shows medullary breast cancer is a subgroup of basal breast cancers. Cancer Res. 2006 May 1;66:4636-44.
54. Rouzier R, Perou CM, Symmans WF, et al. Breast cancer molecular subtypes respond differently to preoperative chemotherapy. Clin Cancer Res. 2005 Aug 15;11(16): 5678-85.
55. Conforti R, Boulet T, Tomasic G. Breast cancer molecular subclassification and estrogen receptor expression to predict efficacy of adjuvant anthracyclines-based chemotherapy: a biomarker study from two randomized trials. Ann Oncol. 2007 May 21;[Epub ahead of print].
56. Bradley CJ, Given CW, Roberts C. Race, socioeconomic status, and breast cancer treatment and survival. J Natl Cancer Inst. 2002 Apr 3;94(7):490-6.
57. Carey LA, Perou CM, Livasy CA, et al. Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study. JAMA. 2006 Jun 7;295(21):2492-502.
58. Ashing-Giwa KT, Padilla G, Tejero J, et al. Understanding the breast cancer experience of women: a qualitative study of African American, Asian American, Latina and Caucasian cancer survivors. Psychooncology. 2004 Jun;13(6):408-28.
59. Pérez-Stable EJ, Sabogal F, Otero-Sabogal R, et al. Misconceptions about cancer among Latinos and Anglos. JAMA. 1992 Dec 9;268(22):3219-23.
60. Centers for Disease Control and Prevention (CDC). Behavioral Risk Factor Surveillance System Survey Data. Atlanta, GA: U.S. Department of Health and Human Services, CDC, 2006.
61. Ramirez AG, Talavera GA, Villarreal R, et al. Breast cancer screening in regional Hispanic populations. Health Educ Res. 2000 Oct;15(5):559-68.
62. Gomez SL, Glaser SL. Misclassification of race/ethnicity in a population-based cancer registry (United States). Cancer Causes Control. 2006 Aug;17(6):771-81.
63. Stewart SL, Swallen KC, Glaser SL, et al. Comparison of methods for classifying Hispanic ethnicity in a population-based cancer registry. Am J Epidemiol. 1999 Jun 1;149(11):1063-71.
64. Swallen KC, West DW, Stewart SL, et al. Predictors of misclassification of Hispanic ethnicity in a population-based cancer registry. Ann Epidemiol. 1997 Apr;7(3):200-6.
65. U.S. Census Bureau. Hispanic population passes 40 million, Census Bureau reports. Washington, DC: U.S. Census Bureau, 2005. Available at http://www.census.gov/Press-Release/www/releases/archives/population/005164. html.